The scientific advances in cell therapy are significant and hold promise for those suffering from a multitude of conditions, including Alzheimer’s disease, cancer, and diabetes.
The U.S. lacks both the regulatory tools and the incentives to promote the advancement of cell therapies for Americans.
Patients can’t wait – Congress should support and pass the REGROW Act (S. 2689 / H.R. 4762) to bring regenerative cell therapies to the United States.
Do you like this page?